These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34517852)

  • 1. The genomic profiling and MAMLD1 expression in human and canines with Cushing's disease.
    Wang A; Neill SG; Newman S; Tryfonidou MA; Ioachimescu A; Rossi MR; Meij BP; Oyesiku NM
    BMC Endocr Disord; 2021 Sep; 21(1):185. PubMed ID: 34517852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease.
    de Bruin C; Hanson JM; Meij BP; Kooistra HS; Waaijers AM; Uitterlinden P; Lamberts SW; Hofland LJ
    Endocrinology; 2008 Sep; 149(9):4357-66. PubMed ID: 18483151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
    Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
    Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
    Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma.
    Sato A; Ochi H; Harada Y; Yogo T; Kanno N; Hara Y
    Domest Anim Endocrinol; 2017 Jan; 58():126-133. PubMed ID: 26542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
    Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.
    Sbiera S; Tryfonidou MA; Weigand I; Grinwis GC; Broeckx B; Herterich S; Allolio B; Deutschbein T; Fassnacht M; Meij BP
    PLoS One; 2016; 11(12):e0169009. PubMed ID: 28005997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
    Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
    Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing's disease in dogs and humans.
    de Bruin C; Meij BP; Kooistra HS; Hanson JM; Lamberts SW; Hofland LJ
    Horm Res; 2009 Jan; 71 Suppl 1():140-3. PubMed ID: 19153526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
    Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
    Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human ACTH-secreting corticotroph tumoroid model: Novel Human ACTH-Secreting Tumor Cell in vitro Model.
    Zhang D; Hugo W; Redublo P; Miao H; Bergsneider M; Wang MB; Kim W; Yong WH; Heaney AP
    EBioMedicine; 2021 Apr; 66():103294. PubMed ID: 33773184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing's disease.
    Witek P; Maksymowicz M; Szamotulska K; Piaścik A; Wojciechowska-Luźniak A; Stasiewicz A; Witek J; Zieliński G
    Folia Neuropathol; 2020; 58(4):357-364. PubMed ID: 33480240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease.
    Granger N; de Fornel P; Devauchelle P; Segond S; Delisle F; Rosenberg D
    J Vet Intern Med; 2005; 19(1):23-8. PubMed ID: 15715043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.
    Cassarino MF; Ambrogio AG; Cassarino A; Terreni MR; Gentilini D; Sesta A; Cavagnini F; Losa M; Pecori Giraldi F
    J Neuroendocrinol; 2018 Sep; 30(9):e12628. PubMed ID: 29920815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSP-1 is downregulated and inversely correlates with miR-449c expression in Cushing's disease.
    Ren J; Gu C; Yang Y; Xue J; Sun Y; Jian F; Chen D; Bian L; Sun Q
    J Cell Mol Med; 2019 Jun; 23(6):4097-4110. PubMed ID: 31016850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
    Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
    Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.